Tranquility Partners LLC Increases Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Tranquility Partners LLC boosted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 5.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,395 shares of the company’s stock after purchasing an additional 170 shares during the quarter. Tranquility Partners LLC’s holdings in Acadia Healthcare were worth $264,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Acadia Healthcare by 5.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 19,976 shares of the company’s stock worth $1,553,000 after purchasing an additional 1,056 shares during the last quarter. Strs Ohio increased its holdings in Acadia Healthcare by 10.9% during the 4th quarter. Strs Ohio now owns 82,288 shares of the company’s stock worth $6,398,000 after purchasing an additional 8,100 shares during the last quarter. Vontobel Holding Ltd. increased its holdings in Acadia Healthcare by 6.5% during the 4th quarter. Vontobel Holding Ltd. now owns 74,658 shares of the company’s stock worth $5,805,000 after purchasing an additional 4,538 shares during the last quarter. Phocas Financial Corp. purchased a new stake in Acadia Healthcare during the 4th quarter worth approximately $6,887,000. Finally, Louisiana State Employees Retirement System bought a new stake in shares of Acadia Healthcare in the 4th quarter valued at approximately $2,014,000.

Insider Transactions at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 2.80% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Barclays assumed coverage on Acadia Healthcare in a report on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 price target for the company. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Monday, March 4th. Mizuho boosted their price target on Acadia Healthcare from $77.00 to $84.00 and gave the company a “neutral” rating in a report on Wednesday, March 6th. UBS Group boosted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research report on Tuesday, March 5th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Acadia Healthcare has an average rating of “Hold” and an average target price of $91.22.

Acadia Healthcare Price Performance

NASDAQ:ACHC remained flat at $70.25 during trading hours on Thursday. The company had a trading volume of 50,475 shares, compared to its average volume of 556,294. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. Acadia Healthcare Company, Inc. has a 52-week low of $66.49 and a 52-week high of $87.77. The stock has a fifty day moving average price of $79.62 and a two-hundred day moving average price of $77.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.05. The company had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The business’s revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.70 EPS. On average, sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.